Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Hardiman

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Revue Neurologique|April 2, 2026
Neuroimaging confirms selective cerebral involvement in primary lateral sclerosis and predilection to brain regions with high metabolic activityJ Kleinerova, M Tahedl, E Finegan, et al.
Neurology|June 30, 2006
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)N Parkinson, P G Ince, M O Smith, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 11, 2003
A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after strokeS J Pittock, A P Moore, O Hardiman, et al.
Orphanet Journal of Rare Diseases|April 12, 2022
Designing rare disease care pathways in the Republic of Ireland: a co-operative modelA J Ward, D Murphy, R Marron, et al.
Journal of Neurology|April 4, 2025
Rate of change in upper and lower motor neuron burden is associated with survival in amyotrophic lateral sclerosisA Maranzano, F Gentile, M Passaretti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 21, 2007
Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypesJ C Schymick, Y Yang, P M Andersen, et al.
Neurology|March 27, 2009
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALSA-M Wills, S Cronin, A Slowik, et al.
Translational Psychiatry|March 29, 2017
Genetic effects influencing risk for major depressive disorder in China and EuropeT B Bigdeli, S Ripke, R E Peterson, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Revue Neurologique|April 2, 2026
Neuroimaging confirms selective cerebral involvement in primary lateral sclerosis and predilection to brain regions with high metabolic activityJ Kleinerova, M Tahedl, E Finegan, et al.
Neurology|June 30, 2006
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)N Parkinson, P G Ince, M O Smith, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 11, 2003
A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after strokeS J Pittock, A P Moore, O Hardiman, et al.
Orphanet Journal of Rare Diseases|April 12, 2022
Designing rare disease care pathways in the Republic of Ireland: a co-operative modelA J Ward, D Murphy, R Marron, et al.
Journal of Neurology|April 4, 2025
Rate of change in upper and lower motor neuron burden is associated with survival in amyotrophic lateral sclerosisA Maranzano, F Gentile, M Passaretti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 21, 2007
Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypesJ C Schymick, Y Yang, P M Andersen, et al.
Neurology|March 27, 2009
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALSA-M Wills, S Cronin, A Slowik, et al.
Translational Psychiatry|March 29, 2017
Genetic effects influencing risk for major depressive disorder in China and EuropeT B Bigdeli, S Ripke, R E Peterson, et al.
Pageof 7